Generic name: LEMBOREXANT 5mg
Dosage form: tablet, film coated
Drug class: Miscellaneous anxiolytics, sedatives and hypnotics
Medically reviewed by Drugs.com. Last updated on May 25, 2023.
2.1 Dosing Information
The recommended dosage of DAYVIGO is 5 mg taken no more than once per night, immediately before going to bed, with at least 7 hours remaining before the planned time of awakening. The dose may be increased to the maximum recommended dose of 10 mg based on clinical response and tolerability. Time to sleep onset may be delayed if taken with or soon after a meal [see Clinical Pharmacology (12.3)].
2.2 Dosage Recommendations for Concomitant Use with CYP3A Inhibitors or CYP3A Inducers
Co-administration with Strong or Moderate CYP3A Inhibitors
Co-administration with Weak CYP3A Inhibitors
Co-administration with Strong or Moderate CYP3A Inducers
2.3 Dosage Recommendations for Patients with Hepatic Impairment
DAYVIGO is not recommended in patients with severe hepatic impairment [see Use in Specific Populations (8.7)].
Frequently asked questions
More about Dayvigo (lemborexant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (247)
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- En español
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.